Pharma stocks rise up to 6% on defensive buying
On September 21, pharmaceutical shares posted positive sentiment for a third straight day, with Mankind Pharma and Wockhardt among the top gainers; the sector rise is attributed to defensive buying, upcoming product launch pipelines, and regulatory approvals.